Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / LMNX - Luminex nabs BARDA award to fund enhancement of COVID-19 blood test


LMNX - Luminex nabs BARDA award to fund enhancement of COVID-19 blood test

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority ((BARDA)) has awarded $683,500 to Luminex (LMNX) to support the enhancement of its xMAP SARS-CoV-2 Multi-Antigen IgG Assay which detects antibodies to three antigens of the coronavirus.The company intends to submit the updated test to the FDA for emergency use during the pandemic.Shares up 4% after hours.

For further details see:

Luminex nabs BARDA award to fund enhancement of COVID-19 blood test
Stock Information

Company Name: Luminex Corporation
Stock Symbol: LMNX
Market: NASDAQ
Website: luminexcorp.com

Menu

LMNX LMNX Quote LMNX Short LMNX News LMNX Articles LMNX Message Board
Get LMNX Alerts

News, Short Squeeze, Breakout and More Instantly...